Editorial: Platelet and megakaryocyte dysfunctions in infectious diseases

Alice Assinger; Claude Capron; Fernando Real; Morgane Bomsel

doi:10.3389/fimmu.2023.1175200

Editorial: Platelet and megakaryocyte dysfunctions in infectious diseases

Front Immunol. 2023 Mar 28:14:1175200. doi: 10.3389/fimmu.2023.1175200. eCollection 2023.

Authors

Alice Assinger¹, Claude Capron^{2

3}, Fernando Real^{4

5}, Morgane Bomsel^{4

5}

Affiliations

¹ Department of Vascular Biology and Thrombosis Research, Center for Physiology and Pharmacology, Medical University of Vienna, Vienna, Austria.
² Service d'Hématologie Hôpital Ambroise Paré (AP-HP), Boulogne-Billancourt, France.
³ Université de Versailles-St Quentin en Yvelines, Versailles, France.
⁴ Laboratory of Mucosal Entry of HIV and Mucosal Immunity, Institut Cochin, Paris, France.
⁵ INSERM U1016, CNRS UMR8104, Université de Paris Cité, Paris, France.

No abstract available

Keywords: COVID-19; bacteria; bleeding; infection; platelets; thrombosis; viruses.

Publication types

Editorial
Research Support, Non-U.S. Gov't

MeSH terms

Blood Platelets
Communicable Diseases*
Humans
Megakaryocytes*
Platelet Count

Grants and funding

This work is financially supported by the Austrian Federal Ministry of Education, Science and Research, the Medical-Scientific Fund of the Mayor of Vienna (COVID024) and the Austrian Science Fund (P32064 and P34783) to AA. This work is also supported by the French National Agency for Research (ANR)- the Foundation for the Medical Research (FRM) (ANR flash COVID, AFC202010012510: MUCOLUNG) and by the French Agency for AIS research and emerging diseases (ANRS, AO 2019-2 CSS11-19401).